EGFR and non-small cell lung carcinoma: The central nervous system (CNS) is commonly involved in EGFR-mutated NSCLC, with 25–40% of patients having brain metastases at diagnosis, and a further 20–30% of patients developing brain metastases during the disease course [15,16,17].